Honored and grateful to be named as one of the Rogel Scholarship recipients for this year. Big thanks to Carl Koschmann, Koschmann Lab, and @jallenphd for the mentorship over the years, and to U-M Rogel Cancer Center and the Rogel family for this privilege.

Another article highlighting our recent paper led by Evan Cantor tracking treatment response and tumor progression via liquid biopsy of CSF and plasma #DIPG clinicalresearchnewsonline.com/news/2022/05/1…

A $1 million gift from Yuvaan Tiwari Foundation Foundation will accelerate brain tumor research led by Michigan Medicine’s Carl Koschmann, MD. Inspired by Yuvi who died of a diffuse midline glioma at age 3, the foundation offers hope to families facing cancer. michmed.org/PXRYN

👏 👏 Peter G. Delaney, M.D.

The students at @UMichMedAdmiss are what makes Michigan Medicine such an amazing place to work. Student led initiatives like Medical Arabic @ UMMS which aims to teach Medical Arabic to ensure equitable access for all of our patients is just one example… #GoBlue!〽️ AAMC ACGME

We're looking back on our top stories of 2022! @carlkoschmann's team kept busy, discovering that a gene mutation in #Gliomas leads to cell cycle dysregulation and heightened sensitivity to a class of inhibitors. #RogelinReview labblog.uofmhealth.org/lab-report/for…

I am honored and grateful to have served as AOA president and for my induction into AOA alongside an incredible group of @UMichMedAdmiss students and faculty. #GoBlue

Day ☝️ Rachel O'Reggio

Abed Rahman Kawakibi, MD Day ☝🏾s forever, 🤝🏾💪🏾proud of you doc!

Check out this Newsweek article about our most recent publication in Cancer Discovery - Scientists Find New Weapon Against Brain Tumor: 'Major Crack in the Armor' newsweek.com/scientists-fin…

November issue— Clinical efficacy of ONC201 in H3K27M-#DMG, by Vennetilab, Abed Rahman Kawakibi, MD, Sunjong Ji, Sebastian Waszak, Stefan Sweha, Mateus Mota, Matthew Pun, Sharon Gardner, Yazmin Odia, Koschmann Lab et al. bit.ly/3QZMhKv Michigan Medicine U-M Rogel Cancer Center C.S. Mott Children's #DIPG

UChicago Medicine We also want to give a shout out to the residents from the class of 2028 who will be joining us this summer: Abed Rahman Kawakibi, Sophia Kim-Wang, and Ryan Zitter! #match2024 #RadOnc #GME #matchday2024

IT'S GREAT TO BE A MICHIGAN WOLVERINE! 〽️

Check out the latest from UChicagoCancerCenter HN Group - the DEPEND trial. 1) There is strong interest in determining how to incorporate immunotherapy into non-operative management for LA-HNSCC to improve outcomes for high risk HPV-negative patients.

Honored to be on Capitol Hill advocating for the bipartisan ROCR Act and meaningful reforms to prior authorization—advancing patient care through smarter policy. TaritaThomas MD, PhD, MBA Eric Donnelly John White ASTRO ARRO

Read the study that was part of the basis for this new approval: "Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways" aacrjournals.org/cancerdiscover…

For the first time, the FDA has approved a drug, ONC201, for diffuse midline gliomas. Carl Koschmann (Carl Koschmann) answers questions about the U-M research that led to the approval and what it means for patients. Link: michmed.org/WXd3Z

Very grateful for the opportunity and the great mentorship at University of Chicago Radiation Oncology. Special thanks to Rohan Katipally for all the support!